Asciminib (ABL001)

asciminib · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Asciminib (ABL001), covering 2025-11-04 to 2025-11-04. Get the full timeline:

Most recent: Clinical Trial Update: ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML [Phase 1]